Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

10.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.8K
3.8K
Experimental RNAi02:15

Experimental RNAi

8.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.3K
MicroRNAs01:22

MicroRNAs

4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

24.6K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering a modular FAP-targeting ferritin-based drug nanocarrier for enhanced glioblastoma theranostics.

Theranostics·2026
Same author

Structure-guided rational design of ferritin nanocages unlocks thermoresponsive channels for accelerated drug encapsulation.

International journal of biological macromolecules·2026
Same author

Acute pancreatitis in intraductal papillary mucinous neoplasm: a single-center retrospective cohort study with systematic review and meta-analysis.

BMC gastroenterology·2023
Same author

Maternal Exposure to Sulfur Dioxide and Risk of Omphalocele in Liaoning Province, China: A Population-Based Case-Control Study.

Frontiers in public health·2022
Same author

Rational Design, Pharmacomodulation, and Synthesis of [<sup>68</sup>Ga]Ga-Alb-FAPtp-01, a Selective Tumor-Associated Fibroblast Activation Protein Tracer for PET Imaging of Glioma.

ACS sensors·2021
Same author

Integrin α<sub>2</sub>β<sub>1</sub>-targeting ferritin nanocarrier traverses the blood-brain barrier for effective glioma chemotherapy.

Journal of nanobiotechnology·2021

Related Experiment Video

Updated: Mar 26, 2026

Author Spotlight: Decoding RNA Methylation's Role in Pancreatic Cancer - A Single-Base Resolution Study
06:57

Author Spotlight: Decoding RNA Methylation's Role in Pancreatic Cancer - A Single-Base Resolution Study

Published on: July 7, 2023

1.7K

Noncoding RNAs and pancreatic cancer.

Juan-Fei Peng1, Yan-Yan Zhuang1, Feng-Ting Huang1

  • 1Juan-Fei Peng, Yan-Yan Zhuang, Feng-Ting Huang, Shi-Neng Zhang, Department of Gastroenterology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, Guangdong Province, China.

World Journal of Gastroenterology
|January 27, 2016
PubMed
Summary

Noncoding RNAs (ncRNAs), including microRNAs (miRNAs) and long ncRNAs, are crucial in pancreatic cancer development. Their dysregulation offers potential for novel diagnostic and therapeutic strategies.

Keywords:
DiagnosisNoncoding RNAsPancreatic cancerPrognosisTherapy

More Related Videos

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.4K
Pancreatic Tissue Dissection to Isolate Viable Single Cells
08:04

Pancreatic Tissue Dissection to Isolate Viable Single Cells

Published on: May 26, 2023

4.2K

Related Experiment Videos

Last Updated: Mar 26, 2026

Author Spotlight: Decoding RNA Methylation's Role in Pancreatic Cancer - A Single-Base Resolution Study
06:57

Author Spotlight: Decoding RNA Methylation's Role in Pancreatic Cancer - A Single-Base Resolution Study

Published on: July 7, 2023

1.7K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.4K
Pancreatic Tissue Dissection to Isolate Viable Single Cells
08:04

Pancreatic Tissue Dissection to Isolate Viable Single Cells

Published on: May 26, 2023

4.2K

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Noncoding RNAs (ncRNAs) are RNA molecules not translated into proteins.
  • ncRNAs, particularly microRNAs (miRNAs) and long ncRNAs (lncRNAs), are increasingly recognized for their roles in physiological and pathological processes, including cancer.
  • Dysregulation of ncRNAs is implicated in various cancers, but their specific roles in pancreatic cancer are still being elucidated.

Purpose of the Study:

  • To review the current evidence on the vital roles of ncRNAs in pancreatic cancer.
  • To discuss the genetic and epigenetic mechanisms underlying ncRNA dysregulation in pancreatic cancer.
  • To highlight the potential of ncRNAs as diagnostic and therapeutic targets for pancreatic cancer.

Main Methods:

  • Literature review of studies investigating ncRNAs in pancreatic cancer.
  • Analysis of genetic and epigenetic alterations affecting ncRNA expression.
  • Evaluation of the functional impact of ncRNAs on pancreatic cancer pathways.

Main Results:

  • ncRNAs, including miRNAs and lncRNAs, are significantly dysregulated in pancreatic cancer.
  • These ncRNAs regulate key cellular pathways involved in tumorigenesis, proliferation, and metastasis.
  • Evidence suggests ncRNAs can act as both oncogenes and tumor suppressors in pancreatic cancer.

Conclusions:

  • ncRNAs play critical roles in the development and progression of pancreatic cancer.
  • Understanding ncRNA dysregulation provides insights into pancreatic cancer pathogenesis.
  • ncRNAs hold significant promise for the development of novel diagnostic biomarkers and therapeutic interventions for pancreatic cancer.